Dolby Laboratories, Inc.

Informe acción NYSE:DLB

Capitalización de mercado: US$5.8b

Dolby Laboratories Resultados de beneficios anteriores

Pasado controles de criterios 1/6

Los beneficios de Dolby Laboratories han disminuido a una tasa media anual de -0.04%, mientras que en la industria Software los beneficios crecieron en un 31.8% anualmente. Los ingresos han ido creciendo a una tasa media de 1.6% al año. La rentabilidad financiera de Dolby Laboratories es de 8.8%, y sus márgenes netos son de 16.7%.

Información clave

-0.045%

Tasa de crecimiento de los beneficios

1.43%

Tasa de crecimiento del BPA

Crecimiento de la industria Software 17.33%
Tasa de crecimiento de los ingresos1.64%
Rentabilidad financiera8.79%
Margen neto16.70%
Última actualización de beneficios26 Jun 2026

Actualizaciones de resultados anteriores recientes

Recent updates

Actualización de narrativa • Aug 04

DLB: Streaming Partnerships And Buybacks Will Support Measured Future Return Potential

Analysts have nudged their fair value estimate for Dolby Laboratories higher from $60.00 to $62.00, citing updated assumptions that include a revised discount rate, revenue growth outlook, profit margin profile, and future P/E expectation. What’s in the News for Dolby Laboratories Dolby Laboratories reported Q3 fiscal 2026 revenue of US$305 million and GAAP net income of US$29 million, with growth cited in its Video Distribution Program and Dolby OptiView technology.
Seeking Alpha • Jul 20

Dolby Laboratories Valuation Is Compelling Ahead Of Earnings

Summary Dolby Laboratories is now undervalued after a 50%+ decline from its all-time high, trading at 18.7x FCF and 19.7x earnings. DLB's revenue growth remains choppy, but licensing—especially in Broadcast and Mobile—drives solid results and offers mid-single-digit growth potential. Expansion into automotive and increased adoption of Dolby Atmos/Vision by major platforms and automakers support future growth, with modest price increases feasible. I expect DLB to deliver a steady, 'boring' 10% annual return, making it a solid long-term investment at current valuations. Read the full article on Seeking Alpha
Actualización de narrativa • Jul 03

DLB: Streaming Partnerships And Buybacks Will Support Future Upside Potential

Analysts have reduced their fair value estimate for Dolby Laboratories from $68.00 to $60.00. They cite more conservative revenue growth assumptions and a lower future P/E multiple, partly offset by slightly stronger projected profit margins and a modestly higher discount rate.
Artículo de análisis • Jun 20

Dolby Laboratories (DLB) Stock Could Be 33.2% Undervalued After Hitting A One Year Low

Dolby Laboratories (DLB) has slipped to a one year low as technical signals turned negative and selling pressure picked up, even though reported earnings and institutional ownership data continue to point to steady underlying operations. See our latest analysis for Dolby Laboratories. Over the past year, Dolby Laboratories' share price return has steadily weakened, with the stock down 17.63% year to date and the 1 year total shareholder return declining 26.01%. The 5 year total shareholder...
Actualización de narrativa • Jun 18

DLB: World Cup Streaming Deal Will Support Future Share Price Recovery

Analysts have maintained their fair value estimate for Dolby Laboratories at $78.33 per share. Only minor model adjustments to the discount rate, revenue growth, profit margin, and future P/E assumptions were made, resulting in an unchanged price target.
Actualización de narrativa • Jun 04

DLB: Immersive Content Partnerships Will Support Future Share Price Recovery

Analysts have kept their fair value estimate for Dolby Laboratories steady at $78.33, with only very small tweaks to inputs such as the discount rate, long term revenue growth, profit margin and future P/E assumptions guiding the updated price target narrative. What's in the News Dolby reported Q1 revenue growth of 7.1% year over year, topping analyst expectations by 2.8%, while issuing revenue and EPS guidance for the next quarter that came in below market forecasts, contributing to an 11% share price decline after the release.
Actualización de narrativa • May 17

DLB: Expanding Premium Audio Partnerships Will Support Future Share Gains

Analysts have nudged their price target for Dolby Laboratories down from about $81 to roughly $78, reflecting updated assumptions that combine slightly adjusted revenue growth and discount rate inputs with a different outlook on profit margins and future P/E levels. What's in the News Dolby repurchased 1,010,900 shares between December 27, 2025 and March 27, 2026 for US$65 million, bringing total buybacks under its November 3, 2009 authorization to 54,327,604 shares (52.77%) for US$3,159.61 million (company buyback filing).
Actualización de narrativa • May 01

DLB: Expanding Premium Audio Partnerships Will Support Future Share Gains

Analysts have adjusted their price target for Dolby Laboratories from $90.50 to $81.00, reflecting updated assumptions around the discount rate, revenue growth, profit margins, and future P/E expectations. What's in the News Dolby Atmos is being introduced in the new BMW 7 Series through BMW's Bowers & Wilkins Diamond Surround Sound System, which includes up to 36 speakers and 1,965 watts and is aimed at creating a three-dimensional in-car listening experience (Key Developments).
Actualización de narrativa • Apr 17

DLB: Expanding Premium Cinema Footprint And Ongoing Buybacks Will Support Upside

Analysts are keeping their price target for Dolby Laboratories steady at $90.00. They point to only minor adjustments in the discount rate, revenue growth assumptions and profit margin outlook, along with a slightly lower future P/E multiple in their refreshed models.
Actualización de narrativa • Apr 03

DLB: Future Streaming Expansion And Ongoing Buybacks Will Support Upside Outlook

Analysts have maintained their $90.00 price target for Dolby Laboratories, reflecting updated assumptions that include a slightly lower discount rate, modestly higher revenue growth and profit margin, and a slightly reduced future P/E multiple. What's in the News From September 27, 2025 to December 26, 2025, Dolby repurchased 1,044,838 shares for US$70 million, representing 1.09% of shares, completing a total of 53,316,704 shares repurchased for US$3,094.61 million under the buyback announced on November 3, 2009 (company filing).
Actualización de narrativa • Mar 19

DLB: Future Streaming Technology Adoption Will Support A More Optimistic Outlook

Analysts have revised their price target for Dolby Laboratories from $114.00 to $90.00. They cite updated assumptions around revenue growth, profit margins, and a lower future P/E multiple as key drivers of the change.
Actualización de narrativa • Mar 05

DLB: Media Partnerships And Buybacks Will Support Measured Future Returns

Analysts are keeping their price target for Dolby Laboratories steady at $68.00. This points to largely unchanged expectations around fair value, discount rate, revenue growth, profit margin and future P/E assumptions.
Actualización de narrativa • Feb 19

DLB: Broad Media Partnerships And Buybacks Will Support Steady Returns

Analysts maintained their Dolby Laboratories fair value estimate at $68.00, with only minor adjustments to assumptions around discount rate, revenue growth, profit margin, and future P/E informing the updated price target rationale. What's in the News Dolby updated earnings guidance for the second quarter of fiscal 2026, with total revenue estimated at US$375 million to US$405 million and GAAP diluted EPS expected at US$0.94 to US$1.09.
Actualización de narrativa • Feb 04

DLB: Ongoing Technology Adoption Will Support Returns Despite Choppy Macro Conditions

Analysts have trimmed their price targets on Dolby Laboratories to a range of about $85 to $95. This reflects a more cautious stance on the stock while still pointing to solid recent results and ongoing technology adoption, even as the macro backdrop pressures some revenue streams.
Artículo de análisis • Feb 02

Dolby Laboratories, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Investors in Dolby Laboratories, Inc. ( NYSE:DLB ) had a good week, as its shares rose 3.3% to close at US$64.19...
Actualización de narrativa • Jan 21

DLB: Technology Adoption And Solid Execution Will Support Future Share Gains

Narrative Update on Dolby Laboratories The analyst price target for Dolby Laboratories has shifted down to a range of about $85 to $95 per share. Analysts point to a solid fiscal Q4, guidance in line with expectations, and continued technology adoption despite macro headwinds as key reasons for the updated view.
Actualización de narrativa • Jan 06

DLB: Steady Outlook Will Balance Macro Pressures And Expanding Technology Adoption

Analysts have trimmed their price targets for Dolby Laboratories, with recent moves from $100 to $95 and from $95 to $85, as they weigh steady guidance and progress in technology adoption against ongoing macro headwinds affecting foundational revenues. Analyst Commentary Recent research updates show that bearish analysts are trimming their expectations for Dolby Laboratories even as they acknowledge stable guidance and a solid fiscal fourth quarter.
Artículo de análisis • Jan 05

Is There An Opportunity With Dolby Laboratories, Inc.'s (NYSE:DLB) 42% Undervaluation?

Key Insights The projected fair value for Dolby Laboratories is US$109 based on 2 Stage Free Cash Flow to Equity...
Actualización de narrativa • Dec 21

DLB: Cautious Outlook Will Weigh On Shares Despite Expanding Technology Adoption

Analysts have trimmed their fair value estimate for Dolby Laboratories from $74.00 to $68.00, citing slightly higher discount-rate assumptions despite improving revenue growth and profit margin expectations. They continue to support maintaining a constructive long term outlook.
Actualización de narrativa • Dec 07

DLB: Durable Business Model Will Support Future Gains Despite Macro Headwinds

Analysts have trimmed their price targets for Dolby Laboratories by roughly 10 dollars to reflect ongoing macro headwinds to foundational revenues. At the same time, they highlight solid quarterly execution and continued adoption of the company’s technologies as support for maintaining positive ratings.
Actualización de narrativa • Nov 23

DLB: Durable Business Model Will Support Long-Term Stability Amid Macroeconomic Headwinds

Analysts have reduced their fair value price target for Dolby Laboratories from $95.75 to $90.50, citing continued macroeconomic headwinds but also recognizing progress in revenue growth and profitability. Analyst Commentary Recent Street research highlights a mix of optimism about Dolby Laboratories' underlying business strengths and caution regarding ongoing macroeconomic challenges.
Artículo de análisis • Nov 11

The Returns At Dolby Laboratories (NYSE:DLB) Aren't Growing

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
Artículo de análisis • Sep 27

Investor Optimism Abounds Dolby Laboratories, Inc. (NYSE:DLB) But Growth Is Lacking

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 19x, you may...
Actualización de narrativa • Sep 06

Expanding Auto And Device Ecosystems Will Define Immersive Entertainment

Despite Dolby Laboratories' durable business model, growing licensing revenues, and long-term growth potential from strategic partnerships, analysts have trimmed the price target from $103.00 to $95.75 due to uninspiring device markets, macroeconomic uncertainty, and a lack of near-term catalysts. Analyst Commentary Growing licensing revenues and increased adoption across key markets support positive sentiment.

Desglose de ingresos y gastos

Cómo gana y gasta dinero Dolby Laboratories. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

NYSE:DLB Ingresos, gastos y beneficios (USD Millions)
FechaIngresosBeneficiosGastos G+AGastos de I+D
26 Jun 261,354226659266
27 Mar 261,365244657266
26 Dec 251,339241645264
26 Sep 251,349255647262
27 Jun 251,347264640263
28 Mar 251,320257628262
27 Dec 241,315263625263
27 Sep 241,274262605264
28 Jun 241,259212605265
29 Mar 241,269190614269
29 Dec 231,280188615274
29 Sep 231,300201613272
30 Jun 231,287219603263
31 Mar 231,279242591257
30 Dec 221,237183617257
30 Sep 221,254184634261
01 Jul 221,261201639261
01 Apr 221,258216632260
31 Dec 211,243255587259
24 Sep 211,281310557254
25 Jun 211,267293541253
26 Mar 211,228306526251
25 Dec 201,260318538245
25 Sep 201,162231556239
26 Jun 201,189248554238
27 Mar 201,245221570238
27 Dec 191,231206560237
27 Sep 191,242255549238
28 Jun 191,183238550238
29 Mar 191,096201541238
28 Dec 181,057193525239
28 Sep 181,05542507237
29 Jun 181,05637490234
30 Mar 181,147110480233
29 Dec 171,11595474232
29 Sep 171,080206468233
30 Jun 171,072204464235
31 Mar 171,044192463230
30 Dec 161,051208458224
30 Sep 161,026186464220
01 Jul 161,025208470211
01 Apr 16980180470202
01 Jan 16977171467206
25 Sep 15971181461201

Ingresos de calidad: DLB tiene ganancias de alta calidad.

Margen de beneficios creciente: Los actuales márgenes de beneficio(16.7%) de DLB son inferiores a los del año pasado (19.6%).

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: Los beneficios de DLB han disminuido en un 0.04% al año en los últimos 5 años.

Acelerando crecimiento: DLB ha tenido un crecimiento negativo de los beneficios en el último año, por lo que no puede compararse con su media de 5 años.

Beneficios vs. Industria: DLB tuvo un crecimiento negativo de los beneficios (-14.4%) durante el año pasado, lo que dificulta la comparación con la media de la industria Software (27.2%).

Rentabilidad financiera

Alta ROE: La rentabilidad financiera de DLB (8.8%) se considera baja.

Rentabilidad económica

Rendimiento del capital invertido

Descubre empresas con buenos resultados en el pasado

7D

1Y

7D

1Y

7D

1Y

Análisis de la empresa y estado de los datos financieros

DatosÚltima actualización (huso horario UTC)
Análisis de la empresa2026/09/10 00:13
Precio de las acciones al final del día2026/09/10 00:00
Beneficios2026/06/26
Ingresos anuales2025/09/26

Fuentes de datos

Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.

PaqueteDatosMarco temporalEjemplo Fuente EE.UU. *
Finanzas de la empresa10 años
  • Cuenta de resultados
  • Estado de tesorería
  • Balance
Estimaciones del consenso de analistas+3 años
  • Previsiones financieras
  • Objetivos de precios de los analistas
Precios de mercado30 años
  • Precios de las acciones
  • Dividendos, escisiones y acciones
Propiedad10 años
  • Accionistas principales
  • Información privilegiada
Gestión10 años
  • Equipo directivo
  • Consejo de Administración
Principales avances10 años
  • Anuncios de empresas

* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.

A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.

Modelo de análisis y copo de nieve

Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.

Conozca al que diseñó y construyó el modelo de análisis Simply Wall St.

Métricas industriales y sectoriales

Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.

Fuentes analistas

Dolby Laboratories, Inc. está cubierta por 13 analistas. 4 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.

AnalistaInstitución
Vikram KesavabhotlaBaird
Patrick ShollBarrington Research Associates, Inc.
Eric WoldB. Riley Securities, Inc.